Targeting glycolytic pathway with 2-Deoxy-glucose enhances lapatinib sensitivity in HER2-amplified breast cancer

被引：0
|
作者：
Chen, Xiaosong [1 ]
Liu, Junjun [1 ]
Ward, Toby [2 ]
Liu, Xiaofei [2 ]
Mao, Yan [1 ]
Bockhorn, Jessica [2 ]
Shen, Kunwei [1 ]
Pegram, Mark [2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China
[2] Stanford Canc Inst, Stanford, CA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-713
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
713
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Regarding HER2-Amplified Biliary Tract Cancer
    Pant, Shubham
    ONCOLOGIST, 2021, 26 (09): : E1664 - E1664
  • [22] BCIRG 007: Serum HER2 levels in women with metastatic HER2-amplified breast cancer
    Sampson, E. L.
    Valero, V.
    Roche, H.
    Pienkowski, T.
    Canon, J.
    Zhao, Y.
    Carney, W.
    Mackey, J.
    Taupin, H.
    Lindsay, M.
    Buyse, M.
    Slamon, D.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A34 - A34
  • [23] BCIRG 007: Serum HER2 levels in women with metastatic HER2-amplified breast cancer
    Valero, V.
    Roche, H.
    Pienkowski, T.
    Canon, J.
    Zhao, Y.
    Carney, W.
    Mackey, J.
    Taupin, H.
    Buyse, M.
    Slamon, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer
    Yeon, CH
    Pegram, MD
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (05) : 391 - 409
  • [25] Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer
    Christina H. Yeon
    Mark D. Pegram
    Investigational New Drugs, 2005, 23 : 391 - 409
  • [26] Combinatorial therapies of neratinib for HER2-amplified cancer
    Zhao, Ming
    Scott, Stephen
    Evans, Kurt
    Yuca, Erkan
    Saridogan, Turcin
    Demirhan, Mehmet E.
    Kirby, Bryce P.
    Kopetz, Scott
    Diala, Irmina
    Lalani, Alshad S.
    Piha-Paul, Sarina A.
    Meric-Bernstam, Funda
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [27] The NEDD8 pathway as a therapeutic target in HER2-amplified colorectal cancer
    Invrea, Federica
    Carugo, Alessandro
    Arena, Sabrina
    Bardelli, Alberto
    Draetta, Giulio F.
    Medico, Enzo
    CANCER RESEARCH, 2022, 82 (12)
  • [28] The conditional requirement of HER3 in HER2-amplified breast cancers
    Ruiz-Saenz, Ana
    Dreyer, Courtney
    Steri, Veronica
    Campbell, Marcia
    Gulizia, Nathaniel
    Moasser, Mark
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 94 - 95
  • [29] The NEDD8 pathway as a therapeutic target in HER2-amplified colorectal cancer
    Invrea, F.
    Carugo, A.
    Arena, S.
    Draetta, G.
    Bardelli, A.
    Medico, E.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S63 - S63
  • [30] Deficient NOXA in HER2-amplified breast cancer drives kinase inhibitor resistance
    Floros, Konstantinos V.
    Song, Kyung-A
    Lochmann, Timothy L.
    Hughes, Mark T.
    Heisey, Daniel A.
    Harada, Hisashi
    Hu, Bin
    Koblinski, Jennifer
    Souers, Andrew J.
    Leverson, Joel D.
    Faber, Anthony C.
    CANCER RESEARCH, 2017, 77
12345